FEATURED COMPANIES
- Allergan
- Galderma S.A.
- Hoffmann-La Roche AG
- LF Life Sciences Ltd.
- Maruha Nichiro, Inc.
- Sanofi
Global Hyaluronic Acid Market to Reach $15.2 Billion by 2027
Amid the COVID-19 crisis, the global market for Hyaluronic Acid estimated at US$9.5 Billion in the year 2020, is projected to reach a revised size of US$15.2 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Dermal Fillers, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$6.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Osteoarthritis segment is readjusted to a revised 6.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $2.6 Billion, While China is Forecast to Grow at 10.4% CAGR
The Hyaluronic Acid market in the U.S. is estimated at US$2.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 10.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
Ophthalmic Segment to Record 6.8% CAGR
In the global Ophthalmic segment, USA, Canada, Japan, China and Europe will drive the 6.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$1.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.1 Billion by the year 2027, while Latin America will expand at a 8.1% CAGR through the analysis period.
Select Competitors (Total 45 Featured):
Amid the COVID-19 crisis, the global market for Hyaluronic Acid estimated at US$9.5 Billion in the year 2020, is projected to reach a revised size of US$15.2 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Dermal Fillers, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$6.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Osteoarthritis segment is readjusted to a revised 6.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $2.6 Billion, While China is Forecast to Grow at 10.4% CAGR
The Hyaluronic Acid market in the U.S. is estimated at US$2.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 10.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
Ophthalmic Segment to Record 6.8% CAGR
In the global Ophthalmic segment, USA, Canada, Japan, China and Europe will drive the 6.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$1.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.1 Billion by the year 2027, while Latin America will expand at a 8.1% CAGR through the analysis period.
Select Competitors (Total 45 Featured):
- Allergan
- Bloomage Freda Biopharma Co., Ltd.
- Ferring B.V.
- Galderma S.A.
- Genzyme Corp.
- Hoffmann-La Roche AG
- HTL Biotechnology
- LF Life Sciences Ltd.
- Lifecore Biomedical, LLC
- Maruha Nichiro, Inc.
- Saikagaku Corp.
- Salix Pharmaceuticals, Inc.
- Sanofi
- Shiseido Company, Ltd.
- Smith & Nephew Plc
- Zimmer Biomet
Frequently Asked Questions about the Global Market for Hyaluronic Acid
What is the estimated value of the Global Market for Hyaluronic Acid?
What is the growth rate of the Global Market for Hyaluronic Acid?
What is the forecasted size of the Global Market for Hyaluronic Acid?
Who are the key companies in the Global Market for Hyaluronic Acid?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Allergan
- Galderma S.A.
- Hoffmann-La Roche AG
- LF Life Sciences Ltd.
- Maruha Nichiro, Inc.
- Sanofi
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE
1. MARKET OVERVIEW
III. MARKET ANALYSIS
IV. COMPETITION
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Allergan
- Bloomage Freda Biopharma Co. Ltd.
- Ferring B.V.
- Galderma S.A.
- Genzyme Corp.
- Hoffmann-La Roche AG
- HTL Biotechnology
- LF Life Sciences Ltd.
- Lifecore Biomedical, LLC
- Maruha Nichiro, Inc.
- Saikagaku Corp.
- Salix Pharmaceuticals, Inc.
- Sanofi
- Shiseido Company, Ltd.
- Smith & Nephew Plc
- Zimmer Biomet
Note: Product cover images may vary from those shown
